Novel Anticoagulants Versus Vitamin K Antagonists for Cardioversion of Non- Valvular Atrial Fibrillation – A Meta-Analysis of More Than 17000 Patients

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-39925-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

Journal of Clinical Trials in Cardiology
2017English

Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Effectiveness and Safety of 110 or 150 Mg Dabigatran Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation.

British Journal of Clinical Pharmacology
Pharmacology
2018English

Patients With Non-Valvular Atrial Fibrillation on Vitamin K Antagonists or Direct-Acting Oral Anticoagulants: Patients Profile and Long-Term Follow-Up Outcomes

Archivos de cardiolog�a de M�xico (English ed. Internet)
2020English

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2017English

Non-Vitamin K Oral Anticoagulants Versus Warfarin for Patients With Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2016English

Persistence to Vitamin-K Antagonists (Vka) and Novel Oral Anticoagulants (Noacs) in Non-Valvular Atrial Fibrillation (Nvaf): An Observational Study Using a Comprehensive Regional Database in Catalonia, Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy